Financials

News Discussions Technicals Seasonals

BIOWKS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Bio-Works Technologies AB engages in the research and development, manufacturing, and supply of agarose-based resins. Its products include Size Exclusion and Ion Exchange Chromatography; IMAC and Activated resin; OptioBio Glass and BabyBio Columns; and Affinity Chromatography. The company was founded by Jan Hakan Berglöf in 2006 and is headquartered in Uppsala, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

BIOWKS has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company